AEGiS-PRn: On Twentieth Anniversary of World AIDS Day, Expert Urges Greater Global Emphasis on Preventing Pediatric AIDS PRNewswireImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to PRNewswire main menu
DonateNow


On Twentieth Anniversary of World AIDS Day, Expert Urges Greater Global Emphasis on Preventing Pediatric AIDS

PRNewswire - December 1, 2008


-- "A Generation Free of HIV Is Possible," Barnes Says

WASHINGTON, December 1/PRNewswire/ -- On the twentieth anniversary of World AIDS Day, the Elizabeth Glaser Pediatric AIDS Foundation is urging the global community to reach more pregnant mothers with medicines to protect their infants from HIV, and to speed treatment to children around the world living with HIV and AIDS. According to Foundation President and CEO Pamela W. Barnes, great progress has already been made, but more leadership and a commitment of resources are needed to achieve the goal of an HIV-free generation.

In countries with advanced medical care, new medicines and treatments have practically eradicated pediatric AIDS. But around the world, some 1,000 babies are infected with HIV each day, most through mother-to-child transmission. That number used to be much higher, but the efforts of the President's Emergency Plan for AIDS Relief (PEPFAR), national governments, international institutions, and non-governmental organizations have made a real difference. Still, there is much more work to do.

"We know how to prevent babies from contracting HIV from their mothers," said Barnes. "We have the drugs to treat children already infected with HIV, allowing them to grow healthy and strong. But millions of children and families lack access to these life-saving services. Strong leadership has never been more essential. We've made tremendous progress, but too many children are still dying of this disease. We've laid the groundwork. Now it's time to lead the way toward a generation free of HIV. It is possible."

Most of the barriers to treatment exist in the developing world. Women are unaware that treatment exists, there are too few clinics to provide care to all who need it, many clinics do not have needed medications, and some medical professionals lack the training to deliver this care. As a result, only a third of pregnant women with HIV receive medicines to prevent transmission of the virus to their babies, and children lag behind adults in receiving the treatment critical to their survival. It is particularly crucial to identify HIV-positive infants and to begin treatment early. Without this intervention, half will die before their second birthday. In 2007, some 270,000 children died of AIDS-related illnesses.

The Foundation is calling on the U.S. Congress to fully fund PEPFAR, and encouraging governments and non-governmental organizations across the globe to do more to prevent transmission of HIV from mother to child and to provide all children with the treatment they need to survive and thrive.

The Elizabeth Glaser Pediatric AIDS Foundation is working in 18 countries and at more than 3,200 sites to increase access to prevention of mother-to-child transmission (PMTCT) and to treat children and families affected by HIV/AIDS. It is the largest provider of PMTCT services under PEPFAR. Worldwide, it has reached more than 5.7 million pregnant women, and Foundation programs account for almost one third of global PMTCT treatments.

About the Elizabeth Glaser Pediatric AIDS Foundation

The Elizabeth Glaser Pediatric AIDS Foundation is a worldwide leader in the fight against pediatric AIDS. Its innovative research programs, collaborative training initiatives, advocacy efforts, and rapidly expanding international prevention and treatment programs are bringing dramatic changes to the lives of children worldwide.

Source: Elizabeth Glaser Pediatric AIDS Foundation

Robert Yule of Elizabeth Glaser Pediatric AIDS Foundation, +1-202-448-8456, RYule@pedaids.org


081201
PR081203


Copyright © 2008 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019  http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .